| Document |
Document Title |
|
WO/2015/005051A1 |
Provided are a compound and an active light sensitive or radiation sensitive resin composition, which are capable of forming an ultrafine pattern (for example, one having a line width of 50 nm or less), while satisfying high sensitivity,...
|
|
WO/2015/004200A1 |
The invention relates to fluorinated compounds of the following formula (I) wherein -X1 is a sulphur atom; -X2 and X3 are an oxygen atom or a sulphur atom, under the proviso that if one of said X2 and X3 is a sulphur atom, the other of s...
|
|
WO/2015/002301A1 |
Provided is a novel thiol-group-containing compound. Further provided are: an epoxy resin curing agent containing the thiol compound; and a single-liquid epoxy resin composition containing same. Specifically, provided is a thiol-group-co...
|
|
WO/2015/000761A1 |
The present invention relates to a transparent composite composition (a) comprising: a. a resin composition, comprising i. at least one (meth)acrylated oligomer (ia) and/or monomer (ib), ii. at least one polythiol (ii), and iii. optional...
|
|
WO/2014/188762A1 |
The present invention is a radiation-sensitive resin composition which contains a polymer having a structural unit that contains an acid-cleavable group and a compound represented by formula (1). In formula (1), R1 represents a monovalen...
|
|
WO/2014/160786A1 |
The invention is directed to a process for the preparation of thiocarboxylate silane comprising reacting an aqueous solution of a salt of a thiocarboxylic acid with a haloalkyl silane in the presence of a solid inorganic oxide-supported ...
|
|
WO/2014/152453A2 |
The present technology relates to methods of producing various dithioester-containing compounds via continuous flow reactors.
|
|
WO/2014/073561A1 |
A positive electrode active material layer (2), which is mainly composed of an organic compound (a dithione compound, a dione compound, a diamine compound, or the like) having a multi-electron system, is formed on a surface of a positive...
|
|
WO/2014/015047A1 |
The specification provides compositions and methods to treat neurodegenerative diseases.
|
|
WO/2014/001120A1 |
The present invention provides compounds of formula (I). The invention also provides methods of controlling insects, acarines, nematodes or molluscs using the compounds of formula 1.
|
|
WO/2014/002105A1 |
The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use ...
|
|
WO/2013/159224A1 |
Certain 2-carbamo(thio)yl-1,3-dioxopropyl derivatives, or the tautomers and pharmacologically acceptable addition salts thereof are found to be toxic to cancer cells, in part, by inhibiting DNA topoisomerase II enzyme making them candida...
|
|
WO/2013/151161A1 |
Provided are: a novel compound which has excellent cytotoxic activity; and an antitumor agent. Also provided is a method for easily and simply producing the novel compound. Provided are: a compound represented by one of formulae (1)-(4);...
|
|
WO/2013/146437A1 |
[Problem] To provide a novel compound that is useful as an agent for preventing/treating cancer. [Solution] One aspect of the present invention provides a compound expressed by the chemical formula (1) or a pharmaceutically permissible s...
|
|
WO/2013/134869A1 |
The present description relates to compounds of Formula I (A+ X-), a diastereoisomer, an enantiomer, or a mixture thereof, pharmaceutical composition comprising same and uses thereof for gastrointestinal endoscopic and medical imaging ap...
|
|
WO/2013/117843A1 |
Cosmetic composition comprising a multifunctional compound, compound and cosmetic treatment method. The invention relates to a cosmetic composition comprising at least one compound of formula (I): (Z)x-(L)w-(A)y in which: -x and y are in...
|
|
WO/2013/111798A1 |
[Problem] To provide a novel serine racemase inhibitor having a satisfactory activity and satisfactory specificity. [Solution] A serine racemase inhibitor comprising at least one compound selected from a compound group consisting of comp...
|
|
WO/2013/086354A1 |
The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for ...
|
|
WO/2013/067646A1 |
The present application provides processes and intermediates useful in the production of β- aminocarbonyl- or β-aminothiocarbonyl-containing compounds. Provided herein is a process for synthesizing β-aminocarbonyl- or β-aminothiocarb...
|
|
WO/2013/052727A1 |
The instant application describes novel compounds that modulate (in particular, inhibit) Sirt2, with structures according to Formulas (1) and (2) provided herein. The invention is also directed to pharmaceutical compositions thereof, met...
|
|
WO/2013/037984A1 |
The present invention provides an anti-inflammatory agent/anti-oxidant agent conjugate of formula (I) where is selected from the groups of formula (i), (ii) or (iii), L is CH2CH2 and the other variables are as defined in the claims. Anot...
|
|
WO/2013/029648A1 |
A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: - R' is H or F or trifluoromethyl; - R'' is OH or O-alkyl; - R''' is H or F or trifluoromethyl or phenyl or pyridyl; - R'''' is methylene or acy...
|
|
WO/2013/016840A1 |
Disclosed is a novel intermediate used for preparing tapentadol and their analogues, wherein the structure of the intermediate is expressed by formula I or II, and the groups are defined as the description. Also disclosed are the process...
|
|
WO/2013/008835A1 |
An organic light-emitting element comprising a first electrode, a second electrode, and a light-emitting layer disposed between the first electrode and the second electrode; wherein the light-emitting layer includes a host material, a fi...
|
|
WO/2013/007712A1 |
A process for the preparation of a compound of formula (I): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.
|
|
WO/2012/117941A1 |
This electrode active material has general formula (I) or (II) in the constituent units thereof. In the formulas, X is C or Si; and Y1 and Y2, or Y3 and Y4 are mutually different substituent groups selected from S, O, Se, Te, NH, SR1'R2'...
|
|
WO/2012/113829A1 |
The present invention relates to a heat-curable composition comprising (a) at least one compound which is capable of undergoing cationic polymerization; and (b) at least one sulfonium sulfate selected from compounds of the formulae Ia an...
|
|
WO/2012/114926A1 |
Provided is the thioamide compound represented by general formula (1). In general formula (1): R1 represents -OR11 or -NR12R13; R2 and R3 each independently represent a protecting group of an amide group or a hydrogen atom; R11 represent...
|
|
WO/2012/108542A1 |
A novel method for preparing a thiocarboxylic acid S-(fluoroalkyl) ester represented by formula (III) [wherein R1 is methyl, ethyl or phenyl; and R2 is C1-5 fluoroalkyl], characterized by reacting a thiocarboxylic acid represented by for...
|
|
WO/2012/104415A1 |
A process for transforming a group >C=O (I) in a compound into a group >C=S (II) or into a tautomeric form of group (II) in a reaction giving a thionated reaction product, by use of crystalline P2S5·2 C5H5N as a thionating agent. A thio...
|
|
WO/2012/101245A1 |
The present invention relates to a polymerizable composition comprising at least one ethylenically unsaturated, polymerizable compound and at least one oxime sulfonate compound of the formula (I) QAaBbCc where a is 0, 1, 2, 3, 4 or 6, b ...
|
|
WO/2012/080178A1 |
The application relates to the preparation of thiophenols by reacting the corresponding disulfide with hydrogen in the presence of a heterogeneous transition metal hydrogenation catalyst. If the reaction is carried out in the presence of...
|
|
WO/2012/060396A1 |
The purpose of the present invention is to provide a novel trans-2-decenoic acid derivative and a pharmaceutically acceptable salt thereof, and a medicament containing the compound described above as an active component and having a neur...
|
|
WO/2012/035017A1 |
A process for the preparation of a compound of formula (I) which are useful as intermediates in the preparation of pharmaceutically active compounds.
|
|
WO/2012/026931A1 |
Methods of synthesizing 4-alkyl resorcinols and other substituted phenol compounds, according to formula (IV): or salts thereof, are disclosed, wherein the variables are defined herein.
|
|
WO/2012/017400A1 |
The present invention relates to a novel synthesis method for acyl-pantetheine derivatives. The present invention further relates to the use of said synthesized acyl-pantetheine derivatives as a starting material in the enzymatic synthes...
|
|
WO/2011/150347A2 |
Methods and compounds for treating neurological and other disorders are provided. Included is the administering to a subject in need thereof an effective amount of a compound having binding and/or modulation specificity for a TrkB recept...
|
|
WO/2011/146953A1 |
A compound of formula I wherein PROT is an amine protecting group and PROT' is hydrogen; or PROT and PROT' together with the nitrogen atom to which they are attached form a heterocyclic ring as an amine protecting group, and PROT" is a t...
|
|
WO/2011/141705A1 |
The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel cationic lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic ...
|
|
WO/2011/116490A1 |
A preparation method for racecadotril is disclosed, which includes reacting benzylacrylic acid with thioacetic acid, distilling off unreacted thioacetic acid by use of CH2Cl2, condensating the resulting product with benzyl glycinate para...
|
|
WO/2011/114954A1 |
Disclosed are a diaryl sulfone compound represented by general formula (1), and a manufacturing method for the same. The present invention enables the high yield manufacturing of a novel compound using a simple manufacturing process whic...
|
|
WO/2011/093401A1 |
Provided is a novel compound which has a surfactant ability and an ability to control polymerization. A compound represented by general formula (1) or (2). In the formulae, R1 and R3 represent an organic group having a hydrophobic/hydrop...
|
|
WO/2011/075210A2 |
A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound cor...
|
|
WO/2011/070028A1 |
Whilst methodologies for the Kinetic Resolution of alcohols are well established, no analogous direct methods exist for the highly selective, direct catalytic Kinetic Resolution of thiols (i.e., R-SH). The present invention relates to a ...
|
|
WO/2011/069143A1 |
The present invention provides bis-organosulfur compounds of formulae (I) and (II) and compositions comprising the compounds that are effective against animal pests, including parasites. The compounds and compositions may be used for com...
|
|
WO/2011/050994A2 |
This invention relates to the field of biologically active compounds and specifically to closthioamides, pharmaceutical compositions comprising these compounds, and their use as antibiotic, antifungal, and/or cytotoxic agent.
|
|
WO/2011/034364A2 |
The present invention provides a superior method which involves adding a reducing agent for removing side reaction products from polysulfide ester-amides when conducting a reaction between 3-mercaptopropion esters or 3,3'-dithiodipropion...
|
|
WO/2011/012319A1 |
The present invention relates to method for the preparation of an ω-amino-alkane(thio)amide having the general formula (6): Furthermore, novel intermediates and partial reaction steps of the claimed method are disclosed.
|
|
WO/2011/000793A2 |
The present invention relates to a process for the preparation of S-[2-[1-(2-ethylbutyl)cyclohexylcarbonylamino]-phenyl] 2-methylthiopropionate which is a useful pharmaceutical active compound.
|
|
WO/2010/149888A1 |
Compounds of formula (I) in which: R1 represents a hydrogen atom or a group of formula COR4, or else R1 represents a group of formula (A); R2 represents a group of formula NR5R6, or else R2 represents a nitrogen-containing heterocyclic, ...
|
